Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.23.29002 

Mohanned Alnammi, MD discusses a study that assessed the frequency of mucinous degeneration following neoadjuvant therapy and to compare outcomes among patients with nonmucinous, mucinous tumors, and those with mucinous degeneration on MRI. It revealed that mucinous degeneration is relatively uncommon and did not have a clear association with cancer recurrence or patient survival. The study emphasized the limitations of MRI in differentiating between cellular and acellular mucin and indicated a need for more advanced imaging techniques.